Plain-English translation of NCT06081231 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →This study is observing how well an open-source artificial pancreas system works for people living with type 1 diabetes in China. An artificial pancreas system is a combination of an insulin pump, a continuous glucose monitor (which tracks your blood sugar), and a smartphone app that automatically adjusts your insulin doses. The study will compare how well your blood sugar is controlled and how you feel while using the system compared to before you started using it.
Type 1 diabetes requires constant insulin management, and newer automated systems like artificial pancreas can help reduce the burden of daily diabetes care. This study wants to understand how well this affordable, open-source version of the technology actually works in real-world settings for patients in China.
You would not need to make extra visits or undergo special tests beyond your normal diabetes care routine. The researchers will collect information about your blood sugar control from your continuous glucose monitor, review routine lab tests you already get, and ask you questions about how you're feeling and managing your diabetes. They'll gather data before you start the system and then again at 3, 6, 9, and 12 months to see how things have changed.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China
Sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Enrollment target
~500 participants
Started
January 2019
Primary completion
January 2026
Age range
3 Years – 75 Years
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jinhua Yan, PHD,MD
Third Affiliated Hospital, Sun Yat-Sen University